Label: PHENYLEPHRINE HYDROCHLORIDE solution/ drops

  • NDC Code(s): 0065-0343-02, 0065-0349-04, 0065-0349-05
  • Packager: Alcon Laboratories, Inc.
  • Category: HUMAN PRESCRIPTION DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: New Drug Application

Drug Label Information

Updated April 1, 2025

If you are a consumer or patient please visit this version.

  • HIGHLIGHTS OF PRESCRIBING INFORMATION
    These highlights do not include all the information needed to use PHENYLEPHRINE HYDROCHLORIDE OPHTHALMIC SOLUTION, USP safely and effectively. See full prescribing information for PHENYLEPHRINE ...
  • Table of Contents
    Table of Contents
  • 1 INDICATIONS AND USAGE
    Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10%, is indicated to dilate the pupil.
  • 2 DOSAGE AND ADMINISTRATION
    2.1 General Dosing Recommendations - In patients 1 year of age or greater, apply one drop of either phenylephrine hydrochloride ophthalmic solution 2.5% or 10% every 3 to 5 minutes to the ...
  • 3 DOSAGE FORMS AND STRENGTHS
    Phenylephrine hydrochloride ophthalmic solution, USP 2.5% is a clear, colorless to yellow, sterile topical ophthalmic solution containing phenylephrine hydrochloride 2.5%: each mL contains 25 mg ...
  • 4 CONTRAINDICATIONS
    4.1 Cardiac and Endocrine Disease - Phenylephrine hydrochloride ophthalmic solution 10% is contraindicated in patients with hypertension or thyrotoxicosis. Phenylephrine hydrochloride ophthalmic ...
  • 5 WARNINGS AND PRECAUTIONS
    5.1 Topical Ophthalmic Use Only - Phenylephrine hydrochloride ophthalmic solution 2.5% and 10% is not indicated for injection. 5.2 Cardiovascular Reactions - There have been reports of serious ...
  • 6 ADVERSE REACTIONS
    The following serious adverse reactions are described below and elsewhere in the labeling: Cardiovascular Effects [See Warnings and Precautions (5.2)] Elevation in Blood Pressure [See Warnings ...
  • 7 DRUG INTERACTIONS
    7.1 Agents That May Exaggerate Pressor Responses - Concomitant use of phenylephrine and atropine may enhance the pressor effects and induce tachycardia in some patients. Phenylephrine may ...
  • 8 USE IN SPECIFIC POPULATIONS
    8.1 Pregnancy - Animal reproduction studies have not been conducted with topical phenylephrine. It is also not known whether phenylephrine can cause fetal harm when administered to a pregnant ...
  • 10 OVERDOSAGE
    Overdosage of phenylephrine may cause a rapid rise in blood pressure. It may also cause headache, anxiety, nausea, and vomiting, and ventricular arrhythmias. Prompt injection of a rapidly acting ...
  • 11 DESCRIPTION
    Phenylephrine Hydrochloride Ophthalmic Solution, USP is a sterile, clear, colorless to yellow, topical α-adrenergic agonist for ophthalmic use. The active ingredient is represented by the chemical ...
  • 12 CLINICAL PHARMACOLOGY
    12.1 Mechanism of Action - Phenylephrine hydrochloride is an α-1 adrenergic agonist drug that is used in ophthalmology mainly for its mydriatic effect. After topical application to the ...
  • 14 CLINICAL STUDIES
    Pupillary dilation following topical administration of phenylephrine hydrochloride ophthalmic solution has been demonstrated in controlled clinical studies in adults and pediatric patients with ...
  • 16 HOW SUPPLIED/STORAGE AND HANDLING
    Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% is supplied as a sterile, aqueous, topical ophthalmic solution in an opaque, white low density polyethylene (LDPE) bottle with a natural ...
  • 17. PATIENT COUNSELING INFORMATION
    Advise patients not to touch the dropper tip to any surface as this may contaminate the solution. Inform patients that they may experience sensitivity to light and should protect their eyes in ...
  • PRINCIPAL DISPLAY PANEL
    Principal Display Panel Text for Container Label: Phenylephrine Hydrochloride - Ophthalmic Solution, USP - 2.5% Sterile - Rx only - Alcon - 2mL - NDC 0065-0349-05 - Each mL contains ...
  • PRINCIPAL DISPLAY PANEL
    Principal Display Panel Text for Carton Label: Rx only - Sterile - NDC 0065-0349-05 - Phenylephrine - Hydrochloride - Ophthalmic - Solution, USP 2.5% FOR TOPICAL APPLICATION IN THE ...
  • PRINCIPAL DISPLAY PANEL
    Principal Display Panel Text for Container Label: NDC 0065-0349-04 - 15mL - 300066880-0924
  • PRINCIPAL DISPLAY PANEL
    Principal Display Panel Text for Carton Label: NDC 0065-0349-04 - 15mL - 300066872-0924 - SN: LOT: EXP.: GTIN: 00300650349048 - Principal Display Panel Text for Container Label: NDC ...
  • INGREDIENTS AND APPEARANCE
    Product Information